Articles by Orlando López - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Orlando L?pez

Orlando López


Orlando López is an Independent Consultant with over 25 years of software quality assurance experience and more than 18 years in QA and Compliance in the Food and Drug Administration and EU regulated environments. He is a member of the Pharmaceutical Engineering Editorial Review Board. His special interest is the GMP compliance issues applicable to computer systems. Orlando is the author of 2 books: 21 CFR Part 11 - A Complete Guide to International Compliance, published by Sue Horwood Publishing Limited, www.crcpress.com; and Computer Infrastructure Qualification for FDA Regulatory Industries published by Davis Healthcare International Publishing, www.euromed.uk.com. He can be contacted by e-mail at olopez6102@computer-systems-validation.com.

Requirements for Electronic Records Contained in 21 CFR 211
July 18, 2012

The author discusses the regulatory requirements for electronic records contained in Title 21 CFR Part 211 and how they overlap with the requirements set forth in Title 21 CFR Part 11.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
27%
Breakthrough designations
9%
Protecting the supply chain
41%
Expedited reviews of drug submissions
9%
More stakeholder involvement
14%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
FindPharma Custom Search
Click here